Press Releases

 Filter by Provider

The Board of Trustees of the CBRE Global Real Estate Income Fund (NYSE: IGR) (the “Trust”) announces an amendment to the September 2026 monthly distribution previously declared on July 9, 2026. As a result of the Trust’s 1-for-3 reverse stock split, which became effective after close of business on September 4, 2026, the per-share distribution for September 2026 has been adjusted from $0.06 to $0.18 per share (pre-split CUSIP: 12504G100; post-split CUSIP: 12504G878). The total cash distributed to shareholders for September 2026 will remain unchanged from the amount originally declared.

Chime® (NASDAQ: CHYM), America’s #1 choice for banking1, today announced that it has entered into a definitive agreement to acquire Stride Bank, N.A. (“Stride”) for $590 million in cash.2 Stride is a nationally chartered bank that has been Chime's bank partner for more than seven years. Upon closing, Stride will become Chime Bank, N.A. and operate as a wholly owned subsidiary of Chime.

United Rentals, Inc. (NYSE: URI) today announced that it will participate in the Morgan Stanley 14th Annual Laguna Conference on Tuesday, September 15, 2026. The conference will include a presentation by Matt Flannery, chief executive officer and Ted Grace, chief financial officer.

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will participate in two upcoming investor conferences:

Block, Inc. (NYSE: XYZ) today announced that it has submitted an application to the Office of the Comptroller of the Currency (“OCC”) to establish Builders Bank & Trust, N.A. (“Builders Bank”), an uninsured national trust bank.

Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today announced that Javier Szwarcberg, M.D., M.P.H., Chief Executive Officer, will present at the H.C. Wainwright 28th Annual Global Investment Conference on September 15, 2026, at 2:00 p.m. ET in New York.

Genius Sports Limited (“Genius Sports”) (NYSE: GENI), a global leader in sports data and technology, and NBA All-Star and entrepreneur Chris Paul today announced the launch of a new athlete-led sports media company created in partnership with Paul’s Ohh Dip!!! Entertainment and Connor Schell’s Words + Pictures.

Largest comparative meta-analysis of its kind found da Vinci robotic-assisted surgery was associated with shorter hospital stays and a faster return to work compared with laparoscopic and open surgery

Worthington Steel, Inc., (NYSE: WS) announced today that it has signed a domination and profit and loss transfer agreement (“DPLTA”) pursuant to Sections 291 et seq. of the German Stock Corporation Act (AktG) with Kloeckner & Co SE (“Kloeckner”) as the controlled company via its wholly owned subsidiary, Worthington Steel GmbH.

ServiceTitan Veteran Promoted to Lead Sales Organization Through Next Chapter of Growth; Ross Biestman to Remain at the Company for the Remainder of Fiscal Year

LOS ANGELES, Sept. 08, 2026 (GLOBE NEWSWIRE) -- ServiceTitan (NASDAQ: TTAN), the software platform that powers the trades, today announced financial results for the fiscal second quarter ended July 31, 2026.

Revenue of $450 million reflects 26% increase over prior year

WATERTOWN, Mass., Sept. 08, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels to treat a broad range of genetic diseases, will host a virtual Analyst Day on Monday, September 28, 2026 from 12:00 – 1:30 PM ET featuring presentations and Q&A led by CAMP4’s executive leadership team and participation from patient advocates and a leading KOL. To register, click here.

Clearwater Paper Corporation (NYSE: CLW) today released its 2026 Sustainability Report, providing an annual update on the company's progress toward its multiyear sustainability goals.

DENVER, Sept. 08, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced financial results for its fiscal fourth quarter and full year ended June 30, 2026.

SAXONBURG, Pa., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE: COHR), the global leader in photonics, today announces that its Chief Marketing Officer, Dr. Sanjai Parthasarathi, its Chief Technology Officer, Dr. Julie Sheridan Eng and Dr. Giovanni Barbarossa, Special Advisor to CEO, along with other Coherent experts, will participate in key thought leadership sessions at the European Conference on Optical Communication (ECOC) 2026, to be held September 21 – 23, 2026, in Málaga, Spain.

Logitech International (SIX: LOGN) (Nasdaq: LOGI) today announced that during its annual general meeting (AGM) the Company’s shareholders approved a Fiscal Year 2026 cash dividend of CHF 1.36 per share - an increase of CHF 0.10 compared to the previous year’s dividend of CHF 1.26 per share.

CARLSBAD, Calif., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced that Jeff Bertolini has been promoted to the role of Chief Operating Officer, effective immediately. Jeff joined Carlsmed in September 2024, most recently serving as the Company’s Senior Vice President, Operational Excellence and previously, Vice President of Advanced Manufacturing Technologies. Prior to joining Carlsmed, Jeff held senior leadership positions in operations and technology at SI-BONE, NuVasive, and US Surgical.

Suniva, the largest and oldest U.S. merchant manufacturer of high-efficiency monocrystalline silicon solar cells (“Suniva” or the “Company”), today announced the completion of an $835 million capital raise comprising both debt and equity financing. The financing was provided by a group of top-tier financial partners, including Suniva’s largest shareholder and long-term backer, Lion Point Capital, and consists of senior secured credit facilities provided by funds managed by Goldman Sachs Alternatives and I Squared Capital, a second lien credit facility provided by JBA Asset Management, and equity investments by Electron Capital Partners, Orion Infrastructure Capital (OIC), and Rubric Capital Management, along with certain other investors. The new capital will fund construction of Suniva’s second U.S. solar cell manufacturing facility and accelerate the Company’s rapid expansion to a total of 5.5 GW of American-made solar cell capacity, a decisive step toward U.S. energy independence. Roth Capital Partners served as lead private placement agent to Suniva. Gibson, Dunn & Crutcher LLP served as legal counsel to Roth. Rodman & Renshaw served as a financial advisor to Suniva. J.P. Morgan acted as the sole structuring agent to Suniva. Kilpatrick Townsend & Stockton LLP served as legal counsel to Suniva.

Advancing lead program KRSA-028 toward the clinic, with Phase 1 healthy volunteer data expected mid-2027 and interim proof-of-concept data in Alzheimer’s patients anticipated by year-end 2027 or first quarter of 2028

Quarterly Results Reflect Improved Profitability, First Day® Complete Growth and Continued Balance Sheet Progress

Xponential Fitness, Inc. (NYSE: XPOF) (“Xponential” or the “Company”), one of the leading global franchisors of boutique health and wellness brands, today announced the appointment of Jennifer Ryu as Chief Financial Officer, effective as of October 19, 2026, following the previously announced search process. Ms. Ryu will succeed Robert Julian, who has served as interim Chief Financial Officer since March 2026. Mr. Julian will remain a consultant to the Company to ensure a smooth transition.

SOUTH SAN FRANCISCO, Calif., Sept. 08, 2026 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today announced new clinical data for KRASG12C inhibitor BBO-8520 and the strategic prioritization of (i) BBO-8520 in combination with checkpoint inhibitor in 2L+ KRASG12C inhibitor-experienced non-small cell lung cancer (NSCLC) patients and (ii) BBO-11818 and BBO-10203 combinations in KRAS-mutant cancers.

Law Offices of Howard G. Smith reminds investors of the upcoming November 2, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (NASDAQ: UNCY) securities between December 29, 2025 and June 29, 2026, inclusive (the “Class Period”).

Braze (Nasdaq: BRZE), the leading customer engagement platform that empowers brands to Be Absolutely EngagingTM, today announced results for its fiscal quarter ended July 31, 2026.

Sea Machines Robotics announced today that it has secured a 5 year Indefinite Delivery Indefinite Quantity (IDIQ) contract to supply its commercial, non-developmental, TRL-9, rapidly deployable autonomy kits to US Special Operations Forces. The contract enables SOF to leverage Sea Machines to supply “drop-in” capability for autonomous command and control on global vessels of opportunity to enhance expeditionary logistics, as well as Intelligence, Surveillance and Reconnaissance (ISR) and maritime security at the tactical edge.

The Federal Home Loan Bank of Dallas (FHLB Dallas) and its members Austin Bank and Woodforest National Bank® (Woodforest) awarded $60,000 in Partnership Grant Program (PGP) funding to Greater Texas Capital Community Finance, doing business as Lending Avenue®. The funds are part of $1.8 million in PGP funds awarded in 2026 by FHLB Dallas and members in its five-state District of Arkansas, Louisiana, Mississippi, New Mexico and Texas, and will help Lending Avenue expand access to small‑dollar loans, technical assistance and financial education for entrepreneurs across East Texas.

Phase 3 LIONHEART-HCM Trial of BHB-1893 in Obstructive Hypertrophic Cardiomyopathy (oHCM) Initiated

Mechelen, Belgium; 08 September 2026, 22.01 CET; regulated information

Immunome, Inc. (the “Company”) (Nasdaq: IMNM), a clinical-stage target oncology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced today that on September 1, 2026, the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) granted inducement awards consisting of non-statutory stock options to purchase an aggregate of 86,500 shares of common stock to four new employees under the Company’s 2024 Inducement Plan. The Compensation Committee approved the stock options as an inducement material to such employees’ employment in accordance with Nasdaq Listing Rule 5635(c)(4).

Mechelen, Belgium; 8 September 2026, 22.01 CET; Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) today announced that the Company will host a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference in New York City at 5:35pm ET on Tuesday, September 15th, 2026.

Event to be webcast live on September 9, 2026 at 7:30 a.m. ET

HAMPTON, N.J., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today that management will participate in a fireside chat at the upcoming Cantor Global Healthcare Conference on September 10, 2026 at 8:00am ET.

Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that the company is scheduled to speak at the following financial conference. The presentation will be webcast live via the Investor Relations section of Align's website at http://investor.aligntech.com. An archived replay will remain on the website for approximately one month.

STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced the appointment of David Bailey as Chief Commercial Officer. Mr. Bailey will join STAAR's executive committee and report to Warren Foust, President and Chief Executive Officer.

– Assembly Bio to share 40% of U.S. development costs and profits for helicase-primase inhibitor program for recurrent genital herpes –

Daix (France), New York (New York, United States), September 8, 2026 – Inventiva (Euronext Paris and NASDAQ: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of an oral therapy for the treatment of metabolic dysfunction-associated steatohepatitis (“MASH”), today announces the presentation of five abstracts at the 12th Paris MASH Meeting taking place September 10-11, 2026, at the Pasteur Institut in Paris, France.

Santa Fe, NM, Sept. 08, 2026 (GLOBE NEWSWIRE) -- The Education Plan®—New Mexico’s 529 direct-sold education savings plans—is encouraging New Mexico families to consider another item to the back-to-school shopping list: a 529 plan. 529 education savings plans can be utilized for a variety of qualified expenses at colleges and universities, as well as certain K-12 expenses (including tuition), trade schools, professional education expenses for certification and credentialing, and more.

Clinical-to-Revenue Intelligence identifies and addresses revenue-impacting issues from the point of care through claim submission, before they reach the payer

JERSEY, Channel Islands, September 8, 2026 (GLOBE NEWSWIRE) -- CoinShares PLC (Nasdaq: CSHR) (“CoinShares” or the “Company”), a leading global asset manager specializing in digital assets operating an institutional-grade platform with integrated Capital Markets capabilities, announced today that it will publish its financial results for the first half of 2026, covering the six months ended June 30, 2026, on Monday, September 14, 2026, before market open.

AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that its Board of Directors has named Harriss T. Currie as its Chief Financial Officer, effective September 9, 2026. Mr. Currie will assume CFO responsibilities from Jason Clemens, who will assist with the transition through October 1, 2026.

Oahu Roofing & Repairs is helping island homeowners and businesses respond to storm damage with rapid roof repairs and hands-on insurance claim assistance.

Patch My PC, a leading provider of automated third-party application management and patching solutions, today announced a strategic partnership with QBS Software, one of EMEA’s largest value-added distributors, to expand access to automated application management and security solutions for resellers, MSPs and technology partners across the region.

NEW YORK - September 08, 2026 - The Embody Lab, an online education platform for mental health practitioners and healing-curious individuals, today released its ranking of the seven breathwork certification programs mental health professionals are turning to for trauma-informed, nervous-system-focused training in 2026. The list evaluates programs on clinical grounding, faculty credentials, and how well breathwork instruction integrates with broader somatic and polyvagal-informed practice. The Embody Lab holds the top position.

NEW YORK - September 08, 2026 - The Embody Lab, an online education platform built for mental health practitioners and healing-curious professionals, today released its ranking of the eight trauma-informed care certification programs therapists are choosing in 2026 — a list built around CE accreditation, somatic methodology, and practitioner-reported depth of clinical application.